BUY
Paladin Labs Inc

His 3rd largest position. A good buy at $63 mark. Thinks they are over capitalized and could institute a dividend.

biotechnology / pharmaceutical
HOLD
Paladin Labs Inc

Would not sell it here. A quarter of the market cap is in cash. Lots of opportunity to do new deals. Lots of growth opportunities to come. The next catalyst could be a share buyback or large special dividend. It’s a keeper.

biotechnology / pharmaceutical
PAST TOP PICK
Paladin Labs Inc

(A Top Pick June 18/12. Up 15.18%.) Still likes. Has a massive cash position but in the last couple of weeks have announced a couple of loan deals where they are lending money to other pharmaceutical companies at a high level of interest. Have also announced some new blockbuster drugs that they are going to market in Canada and the US.

biotechnology / pharmaceutical
PAST TOP PICK
Paladin Labs Inc

(A Top Pick May 7/12. Up 14.55%.) Very high ROC. Sitting on a lot of cash and keeps wondering when they are going to do something major with it. It is starting to make their ROE turn over so he, from a portfolio point of view, will have to make a decision.

biotechnology / pharmaceutical
COMMENT
Paladin Labs Inc

Very consistent earnings. Having their annual meeting next week and he would hope that they will declare a big dividend. Generates about $80 million a year and have about $250 million of cash on their books and no debt.

biotechnology / pharmaceutical
PAST TOP PICK
Paladin Labs Inc

(A Top Pick Jan 13/12. Up 1.73%.) Have a massive amount of cash. Last year’s under performer but looks like it is a star in his portfolio this year.

biotechnology / pharmaceutical
PAST TOP PICK
Paladin Labs Inc

(A Top Pick Dec 12/11. Up 2.79%.) A bit of a weak quarter because of problems in South Africa. Everything is good. The problems in South Africa are just a current quarter type of thing and is part of the consolidation process. Biggest issue going forward is that they have an $850 million market cap with $250 million of cash. In terms of enterprise value to EBITDA it is trading at 6 times. Throws off a ton of excess cash flow.

biotechnology / pharmaceutical
COMMENT
Paladin Labs Inc

They don't have a huge exposure into any one area. We don't get a huge amount of detail on their overseas operations. His bigger issue is the cash keeps building up in this company and is starting to undermine the return on equity.

biotechnology / pharmaceutical
TOP PICK
Paladin Labs Inc
Great, long-term growth stock. Have $250 million in cash and the stock will continue to go up and up. Someday they're going to make a huge acquisition which will result in a huge revision of earnings. Could be a $70 stock in a year’s time.
biotechnology / pharmaceutical
TOP PICK
Paladin Labs Inc
Just delivered a quarter that was a beat. The real story is that they are sitting on a huge pile of cash which they are looking to deploy. When you have an $800 million company with $250 million of cash waiting to spend, impact on earnings will be significant. If you wait for announcements to come out, you are too late. Very attractive level.
biotechnology / pharmaceutical
BUY
Paladin Labs Inc
Growing in parts through acquisition. Thinks they are working on all kinds of stuff that will eventually show up.
biotechnology / pharmaceutical
PAST TOP PICK
Paladin Labs Inc
(A Top Pick March 15/11. Up 37.07%.)
biotechnology / pharmaceutical
TOP PICK
Paladin Labs Inc
Pharmaceuticals, so very defensive earnings. Have to grow 15% annually before management gets bonuses. Long term track record is excellent. Great management.
biotechnology / pharmaceutical
TOP PICK
Paladin Labs Inc
Outstanding value creation. Return on capital close to 40%. 200 Million cash. Can expect big acquisitions to come in the next year or two. CEO is on the mend after an accident.
biotechnology / pharmaceutical
COMMENT
Paladin Labs Inc
CEO suffered a serious head injury from a motorcycle accident, which is why the stock has dropped. Fabulous company with great management.
biotechnology / pharmaceutical
Showing 1 to 15 of 26 entries

Paladin Labs Inc(PLB-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Paladin Labs Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Paladin Labs Inc(PLB-T) Frequently Asked Questions

What is Paladin Labs Inc stock symbol?

Paladin Labs Inc is a OTC stock, trading under the symbol PLB-T on the (). It is usually referred to as or PLB-T

Is Paladin Labs Inc a buy or a sell?

In the last year, there was no coverage of Paladin Labs Inc published on Stockchase.

Is Paladin Labs Inc a good investment or a top pick?

Paladin Labs Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Paladin Labs Inc.

Why is Paladin Labs Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Paladin Labs Inc worth watching?

0 stock analysts on Stockchase covered Paladin Labs Inc In the last year. It is a trending stock that is worth watching.

What is Paladin Labs Inc stock price?

On , Paladin Labs Inc (PLB-T) stock closed at a price of $.